CATUG Biotechnology provides novel CRDMO services with a particular focus on mRNA vaccines and therapeutics as well as 
gene and cell therapy (GCT). Plasmid, mRNA, LNP, and analytical QC are our four fundamental technology platforms. Our strong 
expertise and know-how aim to provide end-to-end solutions to our clients in the life cycle of mRNA therapeutics and GCT product 
development. We customize unique services and creative solutions to fit each client’s needs and timeline.